This article is to present the concept of the electronic prescription model, taking into account legal regulations and technical solutions. Nowadays important changes have happened. In 2018, a law package regarding e-prescriptions was introduced in Poland that creates a new tool (electronic prescription) in the Polish market. Homogeneous tools enabling the security and integrity of e-documents and the approval of electronic signatures and seals are particularly important for the operation of the e-prescription. To enable the transmission of e-prescriptions it is required to join basic information and communications technology (ICT) system that supports e-prescribing to the main electronic identification system called Identification Electronic Node. In order to implement the e-prescription model, the lanuching of electronic medical records is indispensable. In most EU countries the e-prescription is implemented with the interchange standard of medical records called Health Level Seven (HL7). In terms of identification and authentication in e-prescribing, the eIDAS regulation plays a significant role. The electronic prescription has long been used in many countries, among which Sweden was one of the earliest (Sjunet system). Patients, physicians, pharmacies and the state will all benefit from the implementation. Ultimately, prescribers would have to use tools that will make it possible to ensure the confidentiality, integrity and credibility of transactions.

According to estimated data, an average Polish hospital manages about 130 thousand pharmaceutical products. The main problem related to pharmacotherapy in hospitals is real-time access to up-to-date data, which determines the correct treatment process. This paper presents the results of research aimed at forecasting the outcome of implementing e-prescriptions in conjunction with barcode scanning on the time of response to a patient’s needs for pharmacotherapy. The research was conducted in two hospitals by means of a business process analysis and the BPMN 2.0 standard. The analysis was concentrated on the drug administration process, taking into consideration the labour and service times of the process. Special attention was given to evaluating the possibilities of getting real-time access to information regarding the type, location and inventory level of pharmaceutical products. The research proved that implementing e-prescriptions in conjunction with barcode scanning could lead to reductions of the average working and service time.

mHealth is seen as the next stage of developing applications for information and communication technologies in the area of health care. This paper presents the evolution of mHealth systems and the results of the latest analyses of the effectiveness of mHealth interventions. Intensive mHealth development results from the near universal access to mobile devices, primarily smartphones, and devices that use sensory technologies. The great interest in mobile applications is reflected in the offer of online stores, which already provide many thousands of programs that can be installed on a mobile phone. Of the many possible mHealth applications, those supporting chronic diseases care and health promotion activities are regarded as the most promising. The growing interest in the area of mHealth is proven by the large number of publications that present syntheses of the available evidence. Although studies aimed at assessing the usefulness and effectiveness of health applications quite often raise doubts about the methodological quality, the significance of the analyses is positive. However, problems in maintaining the involvement of health users in mHealth solutions may be a cause for concern.

Mobile health technologies and applications installed on smart devices still represent new and relatively understudied phenomena in Poland. At the same time, a multitude of applications and their accessibility cause the increase of opportunities for their use for health purposes.

The aim of the present study was to evaluate the interest in applications supporting health and healthy lifestyle as well as monitoring health and disease among 718 adult patients in primary health care. It was found that there is a considerable potential for the increase of future use of health applications. Women, young respondents, respondents who hold an undergraduate degree and assess their health status well were observed to be more likely to potentially use applications related to lifestyle, health monitoring and combating disease.

The aim of the paper is to identify key determinants of effective implementation of innovations in respect to assisted living ecosystems for the elderly. Desk-study as a method was used and EBSCO (including Medline), ScienceDirect, Open Knowledge Repository, and BazEkon databases were researched. The scope of ageing and its key economic and social consequences are portrayed at the beginning. Then main categories of seniors’ needs are presented. Consequently the main ways innovations and new technologies can respond to these needs are identified accompanied by senior citizens’ particular attitude toward new technologies, especially ICT. Then Gerontechnology is presented not only as an important social innovation, but also as a leverage for more effective implementation of innovations and modern technologies in active and assisted living for seniors. The article ends with identification of three key success factors for effective implementation of innovations and new technologies by independently living seniors.

The current challenge for healthcare systems is to assess the clinical and economic value of non-drug technologies. Attempts have been made to use Health Technology Assessment, a standard method used in many countries to assess and make decisions regarding the reimbursement of medicines. The use of health technology assessment for non-drug technology can be a challenge because of the lower availability of high-quality scientific evidence in comparison with drugs. In several European countries attempts were made to develop guidelines for the clinical and economic evaluation of non-drug technologies; we presented specific guidelines prepared by British and French HTA agencies: NICE and HAS, respectively. In the case of Poland, the role of the Agency for Health Technology Assessment and Tariff System (AOTMiT) is to assess and appraise all medical technologies and services claiming public money funding; most of these assessments concern drug technologies. Only 103 of 1,550 orders (6.6%) issued by the Ministry of Health, from 1^st January 2012 to 1^st July 2018, were related to non-drug technologies. The health services assessed by the AOTMiT include different non-drug medical technologies, both specialized medical devices as well as surgical interventions or diagnostic procedures or screenings. Orders for non-drug technologies issued by the Ministry of Health vary in scope and type of assessment.